Professor & Chair
102A Sudro Hall
701-231-7943
Jagdish.Singh@ndsu.edu
Jagdish Singh
Biography
Jagdish Singh is Professor and Chair of the Department of Pharmaceutical Sciences at NDSU College of Pharmacy, North Dakota and is a Fellow of American Association of Pharmaceutical Scientists (AAPS). Singh's research efforts focus on the mechanistic studies for developing and testing novel delivery technologies to deliver biotechnologically derived molecules (e.g., peptide, protein, and gene). US Department of Defense, National Institutes of Health, PhRMA Foundation, and AFPE have funded his research. Singh has published over 130 peer-reviewed papers and 230 abstracts. Singh received twice NDSU College of Pharmacy Researcher of the Year awards and was recognized with Fred Waldron Research Award in Year 2002 in recognition of his outstanding contribution in research and creative activities at NDSU.
Singh teaches Novel Dosage and Drug Delivery Systems to Pharm.D. and graduate students at NDSU and received thrice the North Dakota State University College of Pharmacy Teacher of the Year awards. He was also recognized twice as a preferred professor by MortarBoard for his continued service and dedication to the students of NDSU through excellence in academic teaching.
Singh has supervised 28 graduate students as their major advisor. He has also supervised two research associates, and has mentored over two dozen undergraduate and professional (Pharm.D.) research students. Singh has also served/ is serving on advisory committee of 25 graduate students in Pharmaceutical Sciences, Chemistry, Polymers and Coatings at NDSU. Singh believes in a good graduate program and derives pleasure in mentoring large number of graduate students, seeing them maturing as scientists and excelling in their employment after graduation. He was instrumental in developing and implementing the combined Pharm.D./Ph.D. program at NDSU College of Pharmacy.
Singh is a member and actively participates in several national and international professional and scientific societies (e.g., American Association of Advancement of Science, American Association of Pharmaceutical Scientists, American Association of Colleges of Pharmacy, and Controlled Release Society, Inc.). Singh is also a member of United States Pharmacopoeia (1995-current) and serves as member of editorial boards of Pharmaceutical Development and Technology; recent patents on Endocrine Metabolic & Immune Drug Discovery; recent patents in Drug Delivery and Formulation; and reviewer of grants and manuscripts for several pharmaceutical and biomedical journals.
Education
|
Ph.D. |
|
(1982) |
|
Pharmaceutics |
|
BHU Institute of Technology, Varanasi |
|
Postdoctoral Fellowship |
(1985-1988) |
Pharmaceutics |
University of Otago, Dunedin |
|||
|
Postdoctoral Fellowship |
(1992-1994) |
Pharmaceutics |
University of California, San Francisco |
|
2002-present |
|
Chair, Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND |
|
2001-present |
Professor, Pharmaceutical Sciences, North Dakota State University, Fargo, ND |
|
|
1999 - 2001 |
Associate Professor, Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND |
|
|
1994 - 1998 |
Assistant Professor, Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND |
|
|
1990-1992 |
Associate Professor (Reader), Department of Pharmaceutics, BHU Institute of Technology, Varanasi |
|
|
1979 - 1989 |
Assistant/Sr. Assistant Professor (Lecturer/Sr. Lecturer), BHU Institute of Technology, Varanasi |
|
2004: |
|
Fellow, AAPS (American Association of Pharmaceutical Scientists) |
|
2001-2002 |
|
Waldron Research Award in recognition of outstanding research achievement at North Dakota State University |
|
2001-2002 |
Teacher of the Year Award, College of Pharmacy, North Dakota State University |
|
|
2000-2001 |
Researcher of the Year Award, College of Pharmacy, North Dakota State University |
|
|
1999-2000 |
Teacher of the Year Award, College of Pharmacy, North Dakota State University |
|
|
1998-1999 |
Researcher of the Year Award, College of Pharmacy, North Dakota State University |
|
|
1998-1999 |
Preferred Professor by Mortar Board |
|
|
1997-1998 |
Teacher of the Year Award, College of Pharmacy, North Dakota State University |
|
|
1997-1998 |
Preferred Professor by Mortar Board |
|
|
1992-1994 |
Visiting Postdoctoral Fellowship, University of California, San Francisco, CA |
|
|
1977-1979 |
University Grants Committee Postdoctoral Fellowship, New Zealand |
|
|
1977-1979 |
UGC Fellowship, Government of India |
|
|
1973-1977 |
UGC Scholarship, Government of India |
|
2006 - current |
Member, Editorial Board of recent Patents on Drug Delivery and Formulation |
|
|
2006 - current |
Member, Editorial Board of recent Patents on Endocrine Metabolic & Immune Drug Discovery |
|
|
2006 - current |
Member, Editorial Board of Pharmaceutical Development and Technology |
|
|
1995 - current |
|
Member, US Pharmacopeia |
|
|
Member, Golden Key |
|
|
|
Member, Rho Chi (National Pharmacy Honor Society) |
|
|
1994 - current |
Member, American Association for the Advancement of Science |
|
|
1994 - current |
Member, American Association of Colleges of Pharmacy |
|
|
1993 - current |
Member, American Association of Pharmaceutical Scientists |
|
|
1993 - current |
Member, Controlled Release Society, Inc. |
|
|
|
Member, Association of Pharmaceutical Teachers of India |
|
|
1986 - 1988 |
Member, Otago Pharmacological Association, Inc. |
|
|
1986 - 1988 |
Member, Otago Medical School Research Council |
Jagdish Singh
Research
In recent years great progress has been made in pharmacotherapy,
and many important new drugs have been introduced to clinical
medicine. Even greater progress has been achieved in the
biopharmaceutical technology, which has made the precise control of
drug delivery to the body by different routes, using a variety of
sophisticated delivery systems. However, the delivery of proteins
and peptides is somewhat of a "black box." The development of a
whole new generation of potent therapeutic agents based on
biotechnology and genetic engineering has brought the limitations
of conventional drug delivery into sharp focus and is forcing a
fundamental reappraisal of the basic mechanisms of drug absorption
and transport. Many of these exciting new compounds are unstable
polar macromolecules with very short biological half-lives whose
clinical application is prevented by problems with delivery. If
methods can be devised to overcome the natural barriers to their
absorption, transport and uptake, these agents promise to
revolutionize drug therapy and bring enormous benefits to medicine
and mankind. Therefore, my research efforts are directed towards
the mechanistic studies for developing and testing novel
delivery technologies to deliver biotechnologically derived
molecules (e.g., peptide, protein, and plasmid DNA).
The specific research interests are: transdermal delivery of
bioactive materials including proteins and peptides using physical
(iontophoresis, electroporation and ultrasound) and chemical
penetration enhancers; understand the mechanisms of transdermal
transport enhancement, using FT-IR, DSC, Atomic Force Microscopy,
and Electron Microscopy; skin bioengineering and skin irritations;
development of suitable animal model for humans for risk assessment
from percutaneous absorption of pesticides and other environmental
contaminants. Other research interests are drug targeting to lungs
using drug loaded biodegradable microspheres,
conformational and chemical stabilization of proteins in
delivery systems, microencapsulation of biomaterials
including proteins, plasmid DNA, and use of smart
polymers for delivery of peptides and proteins.
Jagdish Singh
Selected Publications (From a list of 120
publications):
1. Babu Medi and Jagdish Singh, Skin targeted DNA vaccine delivery using electroporation in rabbits. II. Safety. International Journal of Pharmaceutics, 308 (1-2), 61-68, 2006.
2. S Chen, R. Pieper, DC Webster and J Singh, Triblock copolymers: Synthesis, characterization, and delivery of a model protein. International Journal of Pharmaceutics, 288 (2), 207-218, 2005.
3. Medi and Jagdish Singh, In Vivo Non-Viral Cutaneous Gene Delivery using Electroporation. International Journal of Pharmaceutics, 294, 53-63, 2005.
4. Somnath Singh and Jagdish Singh, Controlled Release, conformational stability, and biological activity of lysozyme from phase sensitive smart polymer based delivery systems. International Journal of Pharmaceutics, 271, 189-196, 2004.
5. Babu Medi and Jagdish Singh, Electronically facilitated transdermal delivery of human parathyroid hormone (1-34). International Journal of Pharmaceutics, 263, 25-33, 2003.
6. Sumeet K Rastogi and Jagdish Singh, Transepidermal transport enhancement of insulin by lipid extraction and iontophoresis. Pharmaceutical Research,19, 427-433, 2002.
7. Feirong Kang, Ge Jiang, Ann Hinderliter, Patrick P DeLuca, and Jagdish Singh, Stability of a model protein, lysozyme, during emulsification for preparation of lysozyme-loaded PLGA microspheres. Pharmaceutical Research,19, 629-633, 2002.
8. Matthew J Schaefer and Jagdish Singh, Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres. Biomaterials, 23, 3465-3471, 2002.
9. J. Singh, M. Gross, B. Sage, H.T. Davis and H. I. Maibach, Regional variation in skin function and cutaneous irritation due to iontophoresis in human subjects. Food and Chemical toxicology, 39 (11), 1079-1086, 2001.
Jagdish Singh
Teaching
Undergraduate Courses
I am responsible for Pharm. Sci. 369 (Pharmaceutics II) and a
small portion of the calculations for Pharm. Sci 368 (Pharmaceutics
I). Pharmaceutics II emphasizes scientific and professional
judgement regarding the usage of drug delivery systems and devices.
This course deals with the formulation of topical, rectal, vaginal,
prolonged release, inhalation, and injectable dosage and delivery
systems and anticipates the role of drug absorption from such
systems.
I teach Pharmaceutics II through lecturing, actively involving
students in problem solving, and by encouraging reading and
completion of problem assignments. I test the students through
multiple choice questions, short answer and essay exams. In
summary, I think the ability to effectively communicate and to
skillfully use basic physico-chemical principles in the
formulation, dispensing and handling of dosage and delivery systems
is crucial for the success of our graduates. I will continue to
implement and evaluate methods designed to engage students in
active learning and problem solving.
Graduate Courses
I developed and introduced a pharmaceutics and drug delivery
graduate course (Pharm. Sci. 796) in the spring of 1996. This
course deals with principles involved in the transport of drugs
through biologic membranes, dermatotoxicity, colloids and their
application in drug delivery systems, controlled release oral
products, chemical kinetics and its application in stability of
pharmaceutical dosage and delivery systems. I will be offering this
course on an alternate year schedule.
I also offer my graduate students an individual study course,
advanced pharmaceutics (Pharm. Sci. 793), to strengthen their
understanding about the techniques and research topics they are
pursuing in my laboratory. For example, I emphasize Fourier
transform infrared spectroscopy, differential scanning calorimetry,
high performance liquid chromatography, radioimmunoassays, and
topics related to their research including discussions on current
publications in their research areas.